Persistence of immunotherapy survival effects of sipuleucel-T and relationship to postrandomization docetaxel use in phase III studies. Background: Sipuleucel-T is an investigational autologous active ...
A randomized phase II study of apalutamide (APA), androgen deprivation therapy (ADT), or APA + ADT in patients (pts) with biochemically relapsed (BCR) prostate cancer (PC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results